Terms Defined Elsewhere Clause Samples

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Acquisition Proposal Section 5.04(a) Agreement Preamble Audited Financial Statements Section 3.06 Articles of Merger Section 2.05 Balance Sheet Section 3.06 Balance Sheet Date Section 3.06 Basket Section 8.04(a) Benefit Plan Section 3.18(a) Cap Section 8.04(a) Closing Section 2.03 Closing Date Section 2.03 Closing Statement Section 2.02 Common Stock Section 3.04(a) Company Preamble Company Board Recitals Company Board Recommendation Section 3.02(b) Company Charter Documents Section 3.01(a) Company Counsel Section 10.14(a) Company Special Meeting Section 5.05 Company Subsidiary Charter Documents Section 3.01(b) Confidentiality Agreement Section 5.03(c) Continuing Employees Section 5.12(a) Direct Claim Section 8.05(c) Disputed Amounts Section 2.16(b)(iii) Dissenting Shares Section 2.10 D&O Indemnified Party Section 5.11(a) D&O Tail Policy Section 5.11(b) Earn-out Calculation Section 2.17(b)(i) Earn-out Calculation Objection Notice Section 2.17(b)(iii) Earn-out Calculation Statement Section 2.17(b)(i) Earn-out Review Period Section 2.17(b)(ii) Effective Time Section 2.05 End Date Section 9.01 Escrow Funds Section 2.12(b) Excess Working Capital Section 2.16(c)(ii) Financial Statements Section 3.06 FIRPTA Statement Section 6.07 Government Contracts Section 3.09(a)(v) Indemnification Escrow Fund Section 2.12(a)(i) Independent Accountant Section 2.16(b)(iii) Insurance Policies Section 3.14 Interim Balance Sheet Section 3.06 Interim Balance Sheet Date Section 3.06 Interim Financial Statements Section 3.06 iSun Residential Preamble iSun Residential Board Recitals Letter of Transmittal Section 2.11(c) Liabilities Section 3.07 Lockup Period Section 5.15 Majority Holders Section 10.01(e) Material Contracts Section 3.09(a) Material Customers Section 3.13(a) Material Suppliers Section 3.13(b) Merger Recitals Merger Sub Preamble Merger Sub Board Recitals Parent Preamble Parent Board Recitals Parent Equity Awards Section 4.11(b)(i) Parent Indemnitees Section 8.02 Parent Preferred Stock Section 4.11(a) Parent Restricted Share Section 4.11(b)(i) Parent SEC Documents Section 4.01 Parent Securities Section 4.11(b)(ii) Parent Stock Plans Section 4.11(b)(i) Parent Stock Option Section 4.11(b)(i) Parent Subsidiaries Preamble Parent Subsidiary Securities Section 4.11(d) Parent Voting Debt Section 4.11(c) Party Preamble Parties Preamble Permitted ...

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Agreement Preamble Biogen Idec License Agreement Section 4.7 Biogen Idec Supply Agreement Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a) Closing Section 2.3 Closing Date Section 2.3 Company Preamble Company Common Stock Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)

Terms Defined Elsewhere. As used in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following table: Agreement Preamble Amendment to the Company Management Agreement Recitals Articles of Merger 2.2(b) Book-Entry Shares 3.3(b)(i) Cancelled Shares 3.1(b)(v) Certificate of Merger 2.2(b) Certificates 3.3(b)(i) Closing 2.2(a) Closing Date 2.2(a) Code Recitals Company Preamble Company Additional Dividend Amount 6.19(a) Company Affiliate 9.10(a) Company Board Recitals Company Board Recommendation Recitals Company Change of Recommendation 6.3(b) Company Common Stock 3.1(b)(i) Company Contracts 3.2(b) Company DER Consideration 3.2(b) Company Director Designee 2.6 Company Disclosure Letter Article IV Company Dividend Equivalent Right 3.2(b) Company Material Adverse Effect 4.1(a) Company Permits 4.9 Company Plans 4.10(a) Company SEC Documents 4.5(a) Company Series A Preferred Stock 3.1(b)(iii) Company Series B Preferred Stock 3.1(b)(iii) Company Series C Preferred Stock 3.1(b)(iii) Company Special Committee Recitals Company Stockholders Recitals Company Stockholders Meeting 4.4 Confidentiality Agreement 6.7(b) Creditors’ Rights 4.3(a) Delaware LLC Act 2.1 Delaware Secretary of State 2.2(b) e-mail 9.3 Effective Time 2.2(b) End Date 8.1(b)(ii) Exchange Agent 3.3(a) Exchange Fund 3.3(a) Forfeited Phantom Shares 3.2(a) GAAP 4.5(b) Indemnified Liabilities 6.10(a) Indemnified Persons 6.10(a) Joint Proxy Statement 4.4 Letter of Transmittal 3.3(b)(i) Leverage Covenants 6.1(a)(xiv) Maryland Courts 9.7(b) Maryland Department 2.2(b) Material Company Insurance Policies 4.17 Material Parent Insurance Policies 5.17 Merger Recitals Merger Filings 2.2(b) Merger Sub Preamble Merger Sub Sole Member Recitals MGCL 2.1 Operating Partnership 2.1 Parent Preamble Parent Additional Dividend Amount 6.19(b) Parent Affiliate 9.10(b) Parent Board Recitals Parent Board Recommendation 5.3(a) Parent Change of Recommendation 6.4(b) Parent Common Stock Issuance Recitals Parent Contracts 5.16(b) Parent Disclosure Letter Article V Parent Equity Plan 5.2(a) Parent Management Agreement Amendment Recitals Parent Manager Recitals Parent Material Adverse Effect 5.1(a) Parent Permits 5.9 Parent Plans 5.10(a) Parent SEC Documents 5.5(a) Parent Stock Issuance Recitals Parent Stockholders Recitals .pdf 9.5 Per Share Common Merger Consideration 3.1(b)(i) Per Share Preferred Merger Consideration 3.1(b)(iii) Per Share Preferred Series B Merger Consideration 3.1(b)(iii) Per Share Preferred...

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below:

Terms Defined Elsewhere. For purposes of this Agreement, the following terms (as capitalized below) will have the following meanings when used in this Agreement: Action Section 6.10(b) Agreement Preamble Alternative Acquisition Agreement Section 6.04(a) Alternative Proposal Section 6.04(i) Annual Bonus Section 6.06(e) Approval Request Section 6.01(b) Articles of Merger Section 2.03 Book-Entry Shares Section 3.01(a) Burdensome Condition Section 6.07(d) Capex Budget Section 4.13(a)(i) Certificate of Merger Section 2.03 Certificates Section 3.01(a) Change of Recommendation Section 6.04(f) Closing Section 2.02 Closing Date Section 2.02 Code Section 3.02(b)(iii) Common Stock Section 3.01(a) Company Preamble Company Board Recitals Company Disclosure Letter Article IV Company Employee Section 6.06(a) Company Employees Section 6.06(a) Company Incentive Plan Section 6.06(e) Company Product Section 4.21 Company Related Parties Section 8.03(a) Company SEC Reports Section 4.06(a) Company Shareholders’ Meeting Section 6.05(b) Confidentiality Agreement Section 6.03(b) control Definition of Affiliates, Section 1.01 controlled by Definition of Affiliates, Section 1.01 DGCL Section 2.01 Dissenting Shares Section 3.01(c)(ii) Effective Time Section 2.03 End Date Section 8.01(b) Enforcement Expenses Section 8.03(b) Exchange Fund Section 3.02(a) First Extended Date Section 8.01(b) G▇▇▇▇▇▇ S▇▇▇▇ Section 4.25 Indemnified Party Section 6.10(b) Intervening Event Section 6.04(k) Intervening Event Notice Section 6.04(g) Leases Section 4.10(b) Legal Restraint Section 7.01(b) Mass Layoff Section 4.18(a) Material Contract Section 4.13(a) Maximum Amount Section 6.10(c) Measurement Time Section 4.02(a) Merger Recitals Merger Consideration Section 3.01(a) Merger Sub Preamble Multiemployer Plan Section 4.18(j) New Plans Section 6.06(b) Notice Period Section 6.04(f) OFAC Definition of Sanctions, Section 1.01 Old Plans Section 6.06(b) Oregon Act Section 2.01 Owned Real Property Section 4.10(a) Parent Preamble Parent Material Adverse Effect Section 5.01 Parent Related Parties Section 8.03(a) Parties Preamble Party Preamble Paying Agent Section 3.02(a) Payoff Amount Section 6.18 Payoff Letter Section 6.18 Plant Closing Section 4.18(a) President Definition of CFIUS Approval, Section 1.01 Recommendation Section 4.04 Remedial Action Section 6.07(d) Replacement Credit Facility Section 6.01(a)(x)(A)(v) Required Company Shareholder Vote Section 4.24 Sanctioned Countries Definition of Sanctions Target, Section 1.01 Share Sec...

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “Accounts Receivable” Section 4.6(b) “Agreement” Preamble “Agreement of Merger” Section 2.2

Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: 2017 Bonuses 9.3(a) Acquired Assets 1.1(a) Aggregate Threshold 6.5(b)(ii) Agreed Amount 6.3(b) Agreement Preamble Antitrust Approvals 4.3(b) Applicable Cap Amount 6.5(b)(i) Assigned Contracts 1.1(a)(iii) Assumed Liabilities 1.1(c) Assumption Agreements 1.1(c) ▇▇▇▇ of Sale 1.3(b)(iii) Business Benefit Plans 2.16(a) Business Employee 9.3(a) Buyer Preamble Buyer FDA Letters 5.3(d) Buyer Group 1.1(a) Buyer Indemnified Parties 6.1 Buyer Plans 9.3(a) Claim Notice 6.3(b) Claimed Amount 6.3(b) Closing 1.3(a) Closing Date 1.3(a) Closing Net Working Capital 1.4(a) Closing Statement 1.4(a) COBRA 9.3(f) Commercial Business Introduction Commercial Business Balance Sheet Date 2.5(b) Confidentiality Agreement 4.2 Contingent Payment 1.2(b) CTAs 2.9(b) Damages 6.1 DOJ 4.3(a) Domain Name Assignment Agreement 1.3(b)(vi) Downward Adjustment Amount 1.4(c)(i) Draft Allocation 8.5 Electronic Delivery 10.7 Employee Benefit Plan 2.16(a) Employment Practices 2.15(b) Environmental Laws 2.19 Environmental Permits 2.19 ERISA 2.16(a) Estimated Net Working Capital 1.2(e) Excluded Assets 1.1(b) Excluded Liabilities 1.1(d) FDA 2.13(b) Final Allocation 8.5 Final Net Working Capital 1.4(b)(iv) FSA Balances 9.3(a) FSA Participants 9.3(a) FTC 4.3(a) Fundamental Representations 6.4(a) Governmental Entity 2.4(b) Hazardous Substances 2.19 Healthcare Laws 2.13(a) HSR Act 2.4(b) Indemnified Party 6.3(a) Indemnifying Party 6.3(a) Inquiry 4.7(a) IP Assignment Agreements 1.3(b)(vii) IP License Agreement 1.3(b)(iv) Lease 2.8(b) Leased Real Property 2.8(b) Material Contract 2.10(a) Material Customers 2.11 Material Suppliers 2.11 New Buyer Employee 9.3(a) Non-Compete Period 9.9(a) Non-Contingent Bonuses 9.3(c) Non-Solicit Period 9.9(b) Objection Notice 1.4(b)(i) Outside Date 7.1(d)(ii) Parties Preamble Party Preamble Patent Assignment Agreement 1.3(b)(v) Permits 1.1(a)(iv) Pre-Closing Period 4.1(a) Registered Business IP 2.9(a) Regulatory Authority 2.13(b) Regulatory Filings 4.3(a) Reimbursement Amount 9.4(c) Related Agreements 2.3 Restricted Names 9.5 Safety Notice 2.13(d) Secured Notes 4.5 Seller Preamble Seller Board 2.3 Seller Change of Recommendation 4.7(a) Seller Disclosure Letter Article II Seller FDA Letters 5.2(g) Seller FSA 9.3(a) Seller Indemnified Parties 6.2 Seller Related Parties 7.2(b)(v) Seller SEC Documents Article II Seller Termination Fee 7.2(b)(i) Seller Trademarks 9.6 Shire Milestone Payment 9.4(a) Spec...

Terms Defined Elsewhere. The following terms are defined herein in the sections identified below:

Terms Defined Elsewhere. The following terms are defined in this Agreement as follows: “Agreement” Preamble